NAGE

Niagen Bioscience, Inc. Common Stock
NAGE

Overview Fund Activity

42 hedge funds and large institutions have $14.2M invested in Niagen Bioscience, Inc. Common Stock in 2017 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 12 increasing their positions, 11 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
42
Holders Change
-4
Holders Change %
-8.7%
% of All Funds
1.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
12
Reduced
11
Closed
12
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Vanguard Group
Vanguard Group
Pennsylvania
+$366K
2
VF
Virtu Financial
New York
+$272K
3
PHS
Pekin Hardy Strauss
Illinois
+$150K
4
TDC
Thompson Davis & Co
Virginia
+$128K
5
UBS Group
UBS Group
Switzerland
+$93.6K

Top Sellers

1
Goldman Sachs
Goldman Sachs
New York
-$698K
2
ECM
Element Capital Management
New York
-$447K
3
PP
Paloma Partners
Connecticut
-$406K
4
LP
LMR Partners
United Kingdom
-$347K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$293K
Name Holding Trade Value Shares
Change 		Shares
Change %
Simplex Trading
51
Simplex Trading
Illinois
– -$3K -822 Closed
1 2
3